Zimmer Biomet received FDA clearance for the Sidus Stem-Free Shoulder system as a total shoulder arthroplasty solution (124.92 +0.86)
The Sidus system will be available in the United States beginning in the First Quarter of 2018. "The FDA clearance of the Sidus Stem-Free Shoulder system comes at a time when Zimmer Biomet is accelerating the pace of innovation... We launched Sidus in Europe in 2012 and initiated a clinical study in the U.S. in 2015. During that time, the product has demonstrated strong clinical performance. The addition of the Sidus system to Zimmer Biomet's U.S. portfolio reinforces the Company's leadership in the innovation of shoulder solutions."